Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio Breast Cancer Symposium

December 10, 2021

Biotechnology

Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics

May 30, 2025
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025
Rani Therapeutics Announces Research Agreement with Chugai

May 19, 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS

May 19, 2025